Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$2.4B |
| 2 |
STJ
St Jude Medical
STJ
|
+$538M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 4 |
RTX Corp
RTX
|
+$347M |
| 5 |
Microsoft
MSFT
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABAX
3026
DELISTED
Abaxis Inc
ABAX
| $4.04M | ﹤0.01% |
83,259
+8,592
| +12% | +$426K |
|
|
ELP
3027
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $4.04M | ﹤0.01% |
979,238
+775,363
| +380% | +$3.21M |
|
|
WSTC
3028
DELISTED
West Corporation
WSTC
| $4.04M | ﹤0.01% |
165,368
-59,684
| -27% | -$1.46M |
|
|
JPUS
3029
JPMorgan Diversified Return US Equity ETF
JPUS
$462M
| $4.03M | ﹤0.01% |
+63,856
| New | +$3.94M |
|
3030
Preferred Bank
PFBC
$1.25B
| $4.03M | ﹤0.01% |
75,133
+7,558
| +11% | +$410K |
|
3031
SPX Corp
SPXC
$10.7B
| $4.03M | ﹤0.01% |
166,281
-193,341
| -54% | -$4.79M |
|
|
EQC
3032
DELISTED
Equity Commonwealth
EQC
| $4.03M | ﹤0.01% |
129,179
-678,391
| -84% | -$21M |
|
3033
Novavax
NVAX
$1.27B
| $4.03M | ﹤0.01% |
157,349
-10,647
| -6% | -$293K |
|
3034
Pacira BioSciences
PCRX
$1.02B
| $4.02M | ﹤0.01% |
88,152
-32,416
| -27% | -$1.4M |
|
|
RBS.PRS.CL
3035
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $4.02M | ﹤0.01% |
158,590
-8,192
| -5% | -$208K |
|
|
KG
3036
Kestrel Group
KG
$69.7M
| $4.02M | ﹤0.01% |
14,345
-3,222
| -18% | -$1.06M |
|
|
SCS
3037
DELISTED
Steelcase
SCS
| $4.01M | ﹤0.01% |
239,609
-163,078
| -40% | -$2.69M |
|
|
WIN
3038
DELISTED
Windstream Holdings Inc
WIN
| $4.01M | ﹤0.01% |
147,249
+19,583
| +15% | +$700K |
|
3039
Andersons Inc
ANDE
$2.31B
| $4.01M | ﹤0.01% |
105,699
-57,169
| -35% | -$2.21M |
|
|
LMOS
3040
DELISTED
Lumos Networks Corp
LMOS
| $4M | ﹤0.01% |
225,972
+151,221
| +202% | +$2.52M |
|
3041
Pacific Biosciences
PACB
$363M
| $4M | ﹤0.01% |
773,519
+435,774
| +129% | +$2.13M |
|
|
UBA
3042
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $4M | ﹤0.01% |
194,450
-64,769
| -25% | -$1.43M |
|
|
NGHC
3043
DELISTED
National General Holdings Corp
NGHC
| $4M | ﹤0.01% |
168,226
-56,347
| -25% | -$1.37M |
|
3044
Sabra Healthcare REIT
SBRA
$5.34B
| $3.99M | ﹤0.01% |
142,929
-107,409
| -43% | -$2.82M |
|
3045
Movado Group
MOV
$840M
| $3.99M | ﹤0.01% |
159,893
-17,070
| -10% | -$433K |
|
|
JTD
3046
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $3.99M | ﹤0.01% |
266,921
+44,129
| +20% | +$642K |
|
3047
Adeia
ADEA
$3.12B
| $3.98M | ﹤0.01% |
443,504
-282,513
| -39% | -$3.04M |
|
3048
BioCryst Pharmaceuticals
BCRX
$2.36B
| $3.98M | ﹤0.01% |
474,185
+146,220
| +45% | +$1.02M |
|
3049
BancFirst
BANF
$3.81B
| $3.98M | ﹤0.01% |
88,550
-32,718
| -27% | -$1.53M |
|
3050
AMC Entertainment Holdings
AMC
$2.29B
| $3.98M | ﹤0.01% |
12,653
+563
| +5% | +$180K |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was TotalEnergies, an estimated $2.4B.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $2.4B.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.